BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21470370)

  • 21. Effectiveness of Platelet-Rich Plasma to Enhance Healing of Diabetic Foot Ulcers in Patients With Concomitant Peripheral Arterial Disease and Critical Limb Ischemia.
    Kontopodis N; Tavlas E; Papadopoulos G; Pantidis D; Kafetzakis A; Chalkiadakis G; Ioannou C
    Int J Low Extrem Wounds; 2016 Mar; 15(1):45-51. PubMed ID: 25795280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of autologous platelet-rich plasma for diabetic foot ulcers: a systematic review and meta-analysis.
    Su YN; Li J; Feng DH; Lu RR; Dong GX; Zhao DY
    J Wound Care; 2023 Dec; 32(12):773-786. PubMed ID: 38060413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Efficacy of Platelet-Rich Plasma Dressing for Chronic Nonhealing Ulcers: A Meta-Analysis of 15 Randomized Controlled Trials.
    Xia Y; Zhao J; Xie J; Lv Y; Cao DS
    Plast Reconstr Surg; 2019 Dec; 144(6):1463-1474. PubMed ID: 31764670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.
    Driver VR; Hanft J; Fylling CP; Beriou JM;
    Ostomy Wound Manage; 2006 Jun; 52(6):68-70, 72, 74 passim. PubMed ID: 16799184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of Platelet-Rich Plasma for Diabetic Foot Ulcer in Spain.
    Linertová R; Del Pino-Sedeño T; Pérez LG; Aragón-Sánchez J; Andia-Ortiz I; Trujillo-Martín M; Iruzubieta-Barragan FJ; Serrano-Aguilar P
    Int J Low Extrem Wounds; 2021 Jun; 20(2):119-127. PubMed ID: 32037919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous Platelet Rich Plasma Promotes the Healing of Non-Ischemic Diabetic Foot Ulcers. A Randomized Controlled Trial.
    Hossam EM; Alserr AHK; Antonopoulos CN; Zaki A; Eldaly W
    Ann Vasc Surg; 2022 May; 82():165-171. PubMed ID: 34896242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of platelet-rich plasma on healing of lower extremity diabetic skin ulcers: A meta-analysis.
    Fang X; Wang X; Hou Y; Zhou L; Jiang Y; Wen X
    Int Wound J; 2024 Apr; 21(4):e14856. PubMed ID: 38531532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principles of management: the diabetic foot.
    Wieman TJ
    Am J Surg; 2005 Aug; 190(2):295-9. PubMed ID: 16023449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The growing evidence for the use of platelet-rich plasma on diabetic chronic wounds: A review and a proposal for a new standard care.
    Picard F; Hersant B; Bosc R; Meningaud JP
    Wound Repair Regen; 2015 Sep; 23(5):638-43. PubMed ID: 26019054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-Rich Plasma: Optimal Use in Surgical Wounds.
    Bolton L
    Wounds; 2021 Aug; 33(8):219-221. PubMed ID: 34357880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous Platelet-Rich Plasma for Diabetic Foot Ulcer.
    Shao S; Pan R; Chen Y
    Trends Endocrinol Metab; 2020 Dec; 31(12):885-890. PubMed ID: 33199085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case series of patients with chronic foot ulcers treated with autologous platelet-rich plasma.
    Yotsu RR; Hagiwara S; Okochi H; Tamaki T
    J Dermatol; 2015 Mar; 42(3):288-95. PubMed ID: 25615024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of endovascular intervention in patients with diabetic foot ulcer and concomitant peripheral arterial disease.
    Claesson K; Kölbel T; Acosta S
    Int Angiol; 2011 Aug; 30(4):349-58. PubMed ID: 21747354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.
    Dougherty EJ
    Adv Skin Wound Care; 2008 Dec; 21(12):568-75. PubMed ID: 19065083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system predicts wound healing but not major amputation in patients with diabetic foot ulcers treated in a multidisciplinary setting.
    Mathioudakis N; Hicks CW; Canner JK; Sherman RL; Hines KF; Lum YW; Perler BA; Abularrage CJ
    J Vasc Surg; 2017 Jun; 65(6):1698-1705.e1. PubMed ID: 28274750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous platelet rich plasma in the management of non-healing vasculitic ulcers.
    Sriram S; Sankaralingam R; Mani M; Tamilselvam TN
    Int J Rheum Dis; 2016 Dec; 19(12):1331-1336. PubMed ID: 27456208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life of adults with unhealed and healed diabetic foot ulcers.
    Goodridge D; Trepman E; Sloan J; Guse L; Strain LA; McIntyre J; Embil JM
    Foot Ankle Int; 2006 Apr; 27(4):274-80. PubMed ID: 16624217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: A prospective, randomized clinical trial.
    Li L; Chen D; Wang C; Yuan N; Wang Y; He L; Yang Y; Chen L; Liu G; Li X; Ran X
    Wound Repair Regen; 2015; 23(4):495-505. PubMed ID: 25847503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CO
    Monami M; Mirabella C; Scatena A; Nreu B; Zannoni S; Aleffi S; Giannoni L; Mannucci E
    J Endocrinol Invest; 2017 Aug; 40(8):819-822. PubMed ID: 28260184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.